Gleptoferron Labiana 200 mg/ml Solution for Injection

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

Gleptoferron

제공처:

Labiana Life Sciences, S.A.

ATC 코드:

QB03AC91

INN (국제 이름):

Gleptoferron

복용량:

200 milligram(s)/millilitre

약제 형태:

Solution for injection

처방전 유형:

LR: Licensed Retailer as defined in national legislation

치료 그룹:

Pigs

치료 영역:

ZZZ Gleptoferron

치료 징후:

Vitamins and minerals

승인 상태:

Authorised

승인 날짜:

2016-12-23

제품 특성 요약

Health Products Regulatory Authority
21 January 2022
CRN00CH24
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Gleptoferron Labiana 200 mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each ml contains:
​
​
​
Active substance:
​
​
​
Iron (III)
200.00
mg​
(as Gleptoferron 532.6 mg)​
​
​
​
Excipients:
​
​
​
Phenol
​
5.0
​mg
​
For the full list of excipients, see section 6.1
​
​
3 PHARMACEUTICAL FORM
Solution for injection.
A dark brown, slightly viscous, sterile, colloidal, aqueous solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Neonatal pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of iron deficiency anaemia.
4.3 CONTRAINDICATIONS
Do not use in case of:
- Hypersensitivity to gleptoferron complex or any of the excipients.
- In animals with hepatic and/or renal disease.
- Do not administer to piglets suspected to suffer from deficiency of
vitamin E and/or selenium.
- Do not use in clinically diseased animals, especially not in case of
diarrhoea.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The sachet in the low-density polyethylene collapsible bottles with a
nominal capacity of 100 ml and 200 ml should not be
opened until the product is required for use.
Health Products Regulatory Authority
21 January 2022
CRN00CH24
Page 2 of 4
4.5 SPECIAL PRECAUTIONS FOR USE
i) Special precautions for use in animals
Normal aseptic injection techniques should be practised.
Avoid the introduction of contamination during use.
It is advisable to stretch the skin at the injection site to minimize
leakage after withdrawal of the needle.
ii) Special precautions to be taken by the person administering the
veterinary medicinal product to animals
People with known hypersensitivity to the active substance
(gleptoferron) or with hemochromatosis should avoid contact with
the veterinary medicinal product.
Take care to avoid accidental self-injection as well as contact with
the eyes, mouth a